You're using a free limited version of DrugPatentWatch: Upgrade for Complete Access

Last Updated: November 5, 2024

CLINICAL TRIALS PROFILE FOR NABILONE

✉ Email this page to a colleague

« Back to Dashboard

All Clinical Trials for NABILONE

Subscribe to access the full database, or Sign Up
Trial ID	Title	Status	Sponsor	Phase	Start Date	Summary
NCT00272207 ↗	A Trial Assessing the Effect of Nabilone on Pain and Quality of Life in Patients With Fibromyalgia	Completed	Valeant Canada Limited	Phase 2	2006-04-01	The purpose of the study is to determine whether or not the drug Nabilone significantly reduces pain and improves quality of life in patients with fibromyalgia.
NCT00272207 ↗	A Trial Assessing the Effect of Nabilone on Pain and Quality of Life in Patients With Fibromyalgia	Completed	Winnipeg Regional Health Authority	Phase 2	2006-04-01	The purpose of the study is to determine whether or not the drug Nabilone significantly reduces pain and improves quality of life in patients with fibromyalgia.
NCT00381199 ↗	Nabilone Versus Amitriptyline in Improving Quality of Sleep in Patients With Fibromyalgia	Completed	McGill University Health Center	N/A	2006-04-01	Most chronic pain patients with insomnia are currently not well-managed using existing medications. If found to safely improve sleep with chronic pain patients, nabilone could be added to the treatment options available in the management of fibromyalgia and associated symptoms. The principle hypothesis of this study is that nabilone at a dose of 0.5-1mg is as efficacious as amitriptyline at a dose of 10-20mg, in improving sleep quality in patients with fibromyalgia.
>Trial ID	>Title	>Status	>Sponsor	>Phase	>Start Date	>Summary

Clinical Trial Conditions for NABILONE

Condition Name

Chart
Table

Condition Name for NABILONE
Intervention	Trials
Neuropathic Pain	3
Healthy	3
Parkinson Disease	3
[disabled in preview]	0
This preview shows a limited data set Subscribe for full access, or try a Trial

Condition MeSH

Chart
Table

Condition MeSH for NABILONE
Intervention	Trials
Neuralgia	5
Marijuana Abuse	5
Parkinson Disease	3
[disabled in preview]	0
This preview shows a limited data set Subscribe for full access, or try a Trial

Clinical Trial Locations for NABILONE

Trials by Country

Map
Table

Trials by Country for NABILONE
Location	Trials
Canada	17
United States	7
Austria	2
Mexico	1
Denmark	1
This preview shows a limited data set Subscribe for full access, or try a Trial

Trials by US State

Map
Table

Trials by US State for NABILONE
Location	Trials
New York	4
Texas	1
Maryland	1
Massachusetts	1
This preview shows a limited data set Subscribe for full access, or try a Trial

Clinical Trial Progress for NABILONE

Clinical Trial Phase

Chart
Table

Clinical Trial Phase for NABILONE
Clinical Trial Phase	Trials
Phase 4	3
Phase 3	7
Phase 2/Phase 3	4
[disabled in preview]	0
This preview shows a limited data set Subscribe for full access, or try a Trial

Clinical Trial Status

Chart
Table

Clinical Trial Status for NABILONE
Clinical Trial Phase	Trials
Completed	15
Not yet recruiting	10
Unknown status	5
[disabled in preview]	0
This preview shows a limited data set Subscribe for full access, or try a Trial

Clinical Trial Sponsors for NABILONE

Sponsor Name

Chart
Table

Sponsor Name for NABILONE
Sponsor	Trials
University of Manitoba	5
New York State Psychiatric Institute	5
Valeant Canada Limited	3
[disabled in preview]	0
This preview shows a limited data set Subscribe for full access, or try a Trial

Sponsor Type

Chart
Table

Sponsor Type for NABILONE
Sponsor	Trials
Other	45
Industry	10
NIH	4
[disabled in preview]	0
This preview shows a limited data set Subscribe for full access, or try a Trial

Make Better Decisions: Try a trial or see plans & pricing

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.